Congress of psychiatry

WEDNESD
A
Y
THURSD
A
Y
94
SCIENTIFIC
 PROGRAMME
003
  New approach to ADHD – normalization of 
increased background noise after ADHD treatment: 
a neuronal correlate
Emanuel Bubl, Germany
004
  Weight and height in children and adolescents 
with attention-deficit / hyperactivity disorder: a 
longitudinal database study assessing the impact of 
guanfacine, stimulants or no pharmacotherapy
Tobias Banaschewski, Germany
Gary Schneider, Brian L. Feldman, Per A. Gustafsson, 
Brian Murphy, Matthew Reynolds, David R. Coghill, 
William Spalding
005
  Long-term safety and efficacy of guanfacine 
extended release in children and adolescents with 
ADHD
Michael Huss, Germany
Byran Dirks, Joan Gu, Jeffrey H. Newcorn, J. Antoni 
Ramos-Quiroga
006
  Vocal acoustic biomarkers as a diagnostic tool 
in attention deficit hyperactivity disorder (ADHD)
Eike Ahlers, Germany
Georg von Polier, Jörg Langner, Michael Colla, Daina 
Langner
OS-11 (d) 
Oral Presentation Session
10:00 – 11:30
 | 
Room R8
TOPIC 24:
 Forensic psychiatry and assessment
 
Forensische Psychiatrie und Begutachtung
Chairs: 
Nahlah Saimeh, Germany 
Jürgen L. Müller, Germany
001
  Deutschlandweite Stichtagserhebung: Auswer-
tungen 20 Jahre Maßregelvollzug – Veränderungen 
und Aussichten
Christian Riedemann, Germany
Dörte Berthold
002
  Migranten im Maßregelvollzug – Fakten zu 
Baden-Württemberg
Hans-Joachim Traub, Germany
003
  Erste Erfahrungen mit der deutschen Version 
des Structured Interview of Reported Symptoms 
(SIRS-2) – ein Beitrag zur Beschwerdenvalidierung 
in der Begutachtung psychischer Störungen
Thomas Schmidt, Germany
Martin Krüger, Stefan Lanquillon, Utz Ullmann, Stefan 
Watzke, Rolf-Dieter Stieglitz
004
  Ist der VRAG-R auch für die Vorhersage von Ge-
walt- und Sexualstraftaten bei Jugendlichen und jun-
gen Erwachsenen geeignet? Eine Untersuchung zur 
prädiktiven Validität an einem 13-Jahre Follow-up
Marcus Müller, Germany
Priscilla Gregório Hertz, Martin Rettenberger,  
Wolfgang Retz
005
  Die Kindstötung – eine retrospektive Analyse 
unter psychopathologischen, psychosozialen und 
kriminologischen Aspekten
Florence Hellen, Germany
Sandra Verhülsdonk, Christian Lange-Asschenfeldt, 
Birgit Janssen, Benno Hartung
KN-03 
Keynote Lecture
11:45 – 12:45
 | 
Hall B
 
TOPIC 43:
 Social justice
Social discrimination and social justice for people 
with mental illness
Chairs: 
Felice Lieh-Mak, People's Republic of China 
Peter Falkai, Germany
Speaker: 
Dinesh Bhugra, United Kingdom
ST-04 (d) 
State-of-the-Art-Symposium
11:45 – 13:15
 | 
Hall A3
 
TOPIC 3:
 Psychotic disorders
 
Die Psychotherapie der Psychosen 
Chairs: 
Stefan Klingberg, Germany 
Andreas Bechdolf, Germany
001
  Über Wahn reden? Rückfälle durch Psycho- 
therapie verhindern? Evidenzbasierte Psychothera-
pie bei psychotischen Störungen
Stefan Klingberg, Germany
002
  Erste psychotische Symptome bewältigen – 
evidenzbasierte Psychotherapie bei Personen mit 
erhöhtem Psychoserisiko und bei Ersterkrankten
Andreas Bechdolf, Germany
ST-05 State-of-the-Art-Symposium
11:45 – 13:15
 | 
Hall A1
 
TOPIC 4:
 Affective disorders
70 years of lithium research: from serendipity to 
gold standard in mood disorders
Chairs: 
Michael Bauer, Germany 
Michael Gitlin, USA
001
  History and current role of lithium for treat-
ment of mood disorders
Michael Bauer, Germany
002
  Practical guide of lithium therapy and manage-
ment of side effects
Michael Gitlin, USA

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
95
SCIENTIFIC
 PROGRAMME
DF-01 
Discussion Forum
11:45 – 13:15
 | 
Hall A4
 
TOPIC 28:
 History, art and cultural sciences
National Socialism and psychiatry: accounting for 
the past and future prospects
Chairs: 
Frank Schneider, Germany 
Arno Deister, Germany
Discussants: 
Margret Hamm, Germany 
Uwe Neumärker, Germany 
Volker Roelcke, Germany 
Hartmut Traub, Germany
DF-02 
Discussion Forum
11:45 – 13:15
 | 
Room Weimar 1
TOPIC 25:
 Training and continuing education
WPA scientific sections: update on the update on 
the remit and activities
Chairs: 
Afzal Javed, United Kingdom 
George Christodoulou, Greece
Discussants: 
Gisèle Apter, France 
Malcolm Hopwood, Australia 
Gordana Milavic, United Kingdom 
Antonio Geraldo da Silva, Brazil 
Khachatur Gasparyan, Armenia 
Gurvinder Kalra, Australia
001
  Clumping or splitting sections in WPA – risk 
and benefit
Ahmed Okasha, Egypt
002
  The WPA scientific sections: lessons from the 
past and perspectives for the future
George Christodoulou, Greece
003
  WPA sections: an update
Afzal Javed, United Kingdom
S-042 Symposium
11:45 – 13:15
 | 
Hall  A6 / A7
 
TOPIC 12:
 Epidemiology and risk factors
What psychiatrists should know about gun violence?
Chairs: 
Bruce Hershfield, USA 
Sir Simon Wessely, United Kingdom
001
  Gun violence: a psychiatric perspective
Rahn Bailey, USA
002
  Obsessive fear of violence in OCD
Jonathan Hershfield, USA
003
  Violent extremist organizations: what can  
psychiatrists do?
Kenneth Busch, USA
004
  Reducing rates of gun violence
Bruce Hershfield, USA
S-043 Symposium
11:45 – 13:15
 | 
Hall A8
 
TOPIC 17:
 Psychotherapy
The future of psychotherapy – between evidence 
based methods, individual soft skills, and mass 
production
Chairs: 
Elisabeth Schramm, Germany 
Robert Mestel, Germany
001
  Synopsis of change factors in psychotherapy – 
what does this mean for the future?
Robert Mestel, Germany
002
  In pursuit of truth – which therapies will deter-
mine the future?
Bruce Wampold, USA
003
  Internet based therapy – is this the future?
Martin Bohus, Germany
004
  Training in psychotherapy – the presence and 
some prospects on the future
Anton-Rupert Laireiter, Austria
S-044 Symposium
11:45 – 13:15
 | 
Hall A5
 
TOPIC 13:
 Brain imaging, neurophysiology, 
neuropsychology
Neuropsychodynamic mechanisms of depression and 
schizophrenia: a spatiotemporal approach to psycho-
pathology and psychotherapeutic implications
Chairs: 
Heinz Boeker, Switzerland 
Georg Northoff, Canada
001
  What psychopathology can learn from neu-
ropsychodynamic psychiatry: a spatiotemporal 
approach to psychopathology
Georg Northoff, Canada
002
  Neuropsychodynamic approach to depression
Heinz Boeker, Switzerland
003
  Neuropsychodynamic aspects of schizophrenic 
symptoms and their treatment
Peter Hartwich, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
96
SCIENTIFIC
 PROGRAMME
S-045 Symposium
11:45 – 13:15
 | 
Hall Helsinki 1
 
TOPIC 4:
 Affective disorders
How to integrate stress, (epi)genetics and imaging 
with life adversity and what does it tell us about 
major depressive disorder
Chairs: 
Thomas Frodl, Germany 
Veronica O'Keane, Ireland
001
  Allostatic load of life adversity: effects on the 
HPA, inflammatory and epigenetic systems
Veronica O'Keane, Ireland
002
  The influence of stress on the serotonergic 
system, uncovered by PET
Marie Spies, Germany
003
  Disadvantage of social sensitivity: interaction 
of oxytocin receptor genotype and child maltreat-
ment on brain structure
Udo Dannlowski, Germany
S-046 Symposium
11:45 – 13:15
 | 
Hall Paris 1
 
TOPIC 4:
 Affective disorders
Neuroplasticity: new pathways to understand and 
to treat major depression
Chairs: 
Claus Normann, Germany 
Christoph Nissen, Switzerland
001
  Antidepressants rescue stress-induced disrup-
tion of synaptic plasticity in depression
Claus Normann, Germany
002
  Neuroplasticity in stress-related neuropsychiat-
ric disorders: new paths for drug discovery
Maurizio Popoli, Italy
003
  Synaptic mechanisms of antidepressant- 
induced plasticity
Eero Castren, Finland
004
  Synaptic mechanisms of therapeutic sleep 
deprivation in major depression
Christoph Nissen, Switzerland
S-047 Symposium
11:45 – 13:15
 | 
Hall Paris 2
 
TOPIC 29:
 Quality assurance in psychiatry
Quality assurance in mental health care – new 
perspectives
›
 WPA Section: Quality Assurance in Psychiatry
Chairs: 
Wolfgang Gaebel, Germany 
Jack McIntyre, USA
Discussant: 
Jagannathan Srinivasaraghavan, USA
001
  Pharmacotherapy of alcohol use disorder: a 
new format for clinical practice guidelines and  
measures
Jack McIntyre, USA
002
  Quality indicators for national mental health 
care improvement
Wolfgang Gaebel, Germany
003
  National quality measurement in psychiatric 
hospitals – the Swiss perspective
Johanna Friedli, Switzerland
004
  Innovative mental healthcare models in  
Germany and Europe – implementation and quality 
assurance
Birgit Janssen, Germany
S-048 Symposium
11:45 – 13:15
 | 
Hall Berlin 1
 
TOPIC 23:
 Health care research and models, health care 
policy
Developing transdiagnostic clinical services for 
young people based on clinical staging
Chairs: 
Ian Hickie, Australia 
Jan Scott, United Kingdom
001
  Developing transdiagnostic clinical services for 
young people based on clinical staging
Ian Hickie, Australia
002
  Implementation of clinical staging in an  
inpatient setting for young people
Elizabeth Scott, Australia
003
  Developing transdiagnostic services for  
implementation in Colombia
Laura Ospina Pinillos, Australia
Tracey Davenport, Ian Hickie
004
  Implementing transdiagnostic services through 
a national early psychosis framework
Patrick McGorry, Australia

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
97
SCIENTIFIC
 PROGRAMME
S-049 Symposium
11:45 – 13:15
 | 
Hall Berlin 2
 
TOPIC 3:
 Psychotic disorders
Social interaction challenges: the nonverbal commu-
nication deficits in psychosis
Chairs: 
Sebastian Walther, Switzerland 
Rose McCabe, United Kingdom
001
  Nonverbal responsivity in schizophrenia: a 3D 
analysis of patients' social encounters
Mary Lavelle, Sweden
002
  Hand gesture impairments in schizophrenia – 
clinical, prognostic, and imaging correlates
Sebastian Walther, Switzerland
Stephan Bohlhalter, Katharina Stegmayer
003
  Beat gestures and associations with postural 
control in youth at clinical high risk for psychosis
Tina Gupta, USA
004
  Emotion recognition and theory of mind are re-
lated to gray matter volume of the prefrontal cortex 
in schizophrenia
Wiepke Cahn, The Netherlands
S-050 Symposium
11:45 – 13:15
 | 
Hall New York 1
 
TOPIC 18:
 Pharmacotherapy
Brain imaging, pharmacogenetics and therapeutic 
drug monitoring for personalized drug treatment: 
concepts and new guidelines
›
 DGPPN Section: Psychopharmacology
Chairs: 
Gerhard Gründer, Germany 
Ekkehard Haen, Germany
001
  Pharmacogenetics in psychiatry: present and 
future use
Chin-Bin Eap, Switzerland
002
  Consensus guidelines 2018 for therapeutic drug 
monitoring in neuropsychopharmacology
Christoph Hiemke, Germany
003
  Brain imaging for guidance of psychotropic 
drug treatment
Hiroyuki Uchida, Japan
004
  TDM for personalized enhancement of safety 
and efficacy of psychotropic drug treatment
Michael Paulzen, Germany
S-051 Symposium
11:45 – 13:15
 | 
Hall New York 3
 
TOPIC 38:
 Human Rights
Approaches to realizing human rights of people 
with mental illness
›
 WPA Section: Psychiatry, Law and Ethics
›
 WPA Section: Public Policy and Psychiatry
›
 WPA Section: Transcultural Psychiatry
Chairs: 
François Ferrero, Switzerland 
Norman Sartorius, Switzerland
001
  Criteria for a hierarchy of human rights
Norman Sartorius, Switzerland
Petra Gronholm, Graham Thornicroft, Hanfried 
Helmchen
002
  How may international organizations con-
tribute in ensuring human rights for people with 
mental illness
Marianne C. Kastrup, Denmark
003
  Transcultural aspects of human rights for  
mental patients
Driss Moussaoui, Morocco
004
  The Geneva Prize for Human Rights in  
Psychiatry: an overview
François Ferrero, Switzerland
S-052 Symposium
11:45 – 13:15
 | 
Room  M2 / M3
TOPIC 34:
 Psychiatry in developing regions
Overcoming the problems of publication
Chairs: 
Christopher Szabo, South Africa 
Prabha S. Chandra, India
001
  Overcoming the problems of publication in low 
income countries
Peter Tyrer, United Kingdom
002
  Publish or perish – a developing country  
perspective
Dusica Lecic-Tosevski, Serbia
003
  The main gaps for randomized control trials in 
psychiatry
Joao Mauricio Castaldelli-Maia, Brazil
004
  How to write a paper: a hypothesis-based  
approach
Reinhard Heun, United Kingdom

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
98
SCIENTIFIC
 PROGRAMME
S-053 Symposium
11:45 – 13:15
 | 
Room M8
TOPIC 25:
 Training and continuing education
Topics of interest in the training of psychiatrists: 
international perspectives
›
 ZONE 4: Northern South America
Chairs: 
Silvia Gaviria, Colombia 
Edgard Belfort, Venezuela
001
  Gender sensitive medicine in medical education 
and psychiatry specialty training
Rutger Jan van der Gaag, The Netherlands
002
  Routes and analysis of the core curriculum 
construction in psychiatric training
Edgard Belfort, Venezuela
003
  Current perspectives on the psychiatric specialty 
in Latin America: education and practice
Silvia Gaviria, Colombia
004
  A review of psychiatric literature in Latin Amer-
ica and its possible impact in the future of training 
across the continent and the world
Renato Alarcon, USA
S-054 Symposium
11:45 – 13:15
 | 
Room Weimar 5
TOPIC 20:
 Prevention and health promotion
Children of parents with mental disorders: needs 
assessment and model interventions
Chair: 
Giulia Signorini, Italy
001
  The needs of children who have parents suffering 
from severe mental disorders
Giulia Signorini, Italy
002
  Dutch intervention programmes for children of 
mentally ill parents
Therese van Amelsvoort, The Netherlands
Karin van Doesum, Floor van Santvoort
003
  The Danish High Risk and Resilience Study VIA 
7 – first results and future perspectives
Anne A. E. Thorup, Denmark
004
  Next steps in the research on children of men-
tally ill parents
Hanna Christiansen, Germany
S-055 Symposium
11:45 – 13:15
 | 
Room Lindau 3
TOPIC 38:
 Human Rights
Mental health, migrants and torture
›
 WPA Section: Psychological Consequences of Torture 
& Persecution
Chairs: 
Pau Perez Sales, Spain 
Joost den Otter, Greece
001
  Migrants in administrative detention: who 
cares for their mental health?
Joost den Otter, Greece
002
  War, trauma and torture survivor refugees in 
Hungary
Lilla Hardi, Hungary
003
  The Istanbul Protocol as a guideline in aspects 
of refugee care – legal and transcultural aspects
Thomas Wenzel, Austria
004
  Working with a traumatized Muslim community 
in Northern California
Laurel Benhamida, USA
S-056 Symposium
11:45 – 13:15
 | 
Room Lindau 6
TOPIC 42:
 Population movements
International refugee movements and their impli-
cations for emergency treatment and mental health 
care systems
Chairs: 
Levent Küey, Turkey 
Ulrike Kluge, Germany
001
  Access to mental health services for refugee 
populations in the UK
Nasir Warfa, United Kingdom
002
  The impact of political, legal and social dimen-
sions of current trends in international movement 
of people for mental health care
Ulrike Kluge, Germany
003
  Refugee health and access to collected research 
data – the information we have, the information we 
need
Andrea Gaddini, Italy
004
  Mental health care service for refugee popula-
tions in Germany and implications for the mental 
health care structure
Marion C. Aichberger, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
99
SCIENTIFIC
 PROGRAMME
S-057 Symposium
11:45 – 13:15
 | 
Room Dessau 3
TOPIC 23:
 Health care research and models, health care 
policy
What is needed to reduce aggression and coercion 
in psychiatric wards?
Chairs: 
Lieselotte Mahler, Germany 
Yasser Khazaal, Switzerland
001
  How do we reduce coercion in mental health 
care?
Andrew Molodynski, United Kingdom
002
  Acute psychiatry: recovery orientated struc-
tures and attitudes reduce aggression and coercion
Lieselotte Mahler, Germany
003
  Psychiatric advance directives: a possible way 
to overcome coercion and promote empowerment
Yasser Khazaal, Switzerland
004
  A standardized debriefing session of coercive 
measures as a way to reduce coercion
Alexandre Wullschleger, Germany
Angelika Vandamme, Christiane Montag, Lieselotte 
Mahler
S-058 Symposium
11:45 – 13:15
 | 
Room R3
TOPIC 15:
 Cross-disorder mechanisms and principles
Smartphone monitoring to improve diagnostics and